+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hypercholesterolemia Drug"

Hypercholesterolemia Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hypercholesterolemia Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
Hypercholesterolemia Market Report 2026 - Product Thumbnail Image

Hypercholesterolemia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
Homozygous Familial Hypercholesterolemia Market Report 2026 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia Market Report 2026

  • Report
  • March 2026
  • 250 Pages
  • Global
From
From
Familial Hypercholesterolemia Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Familial Hypercholesterolemia Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
From
Simvastatin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Simvastatin Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
Metabolic Disorders Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Metabolic Disorders Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
PCSK9 Antagonists Market - Global Forecast 2026-2032 - Product Thumbnail Image

PCSK9 Antagonists Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
From
PCSK9 Targeted Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

PCSK9 Targeted Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
Pitavastatin Calcium Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pitavastatin Calcium Tablets Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
From
From
Metabolic Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Metabolic Disorder Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 286 Pages
  • Global
From
Loading Indicator

The Hypercholesterolemia Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of high cholesterol levels. Hypercholesterolemia drugs are used to reduce the amount of cholesterol in the blood, which can help reduce the risk of heart attack and stroke. These drugs are typically prescribed to patients with high cholesterol levels, or those at risk of developing cardiovascular disease. Commonly prescribed drugs include statins, bile acid sequestrants, fibrates, and cholesterol absorption inhibitors. The Hypercholesterolemia Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Sanofi, AstraZeneca, Novartis, and Bristol-Myers Squibb. Show Less Read more